Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;96(2):545-558.
doi: 10.1007/s00204-021-03195-w. Epub 2022 Jan 10.

SUMOylation regulates the number and size of promyelocytic leukemia-nuclear bodies (PML-NBs) and arsenic perturbs SUMO dynamics on PML by insolubilizing PML in THP-1 cells

Seishiro Hirano  1 , Osamu Udagawa  2
Affiliations

SUMOylation regulates the number and size of promyelocytic leukemia-nuclear bodies (PML-NBs) and arsenic perturbs SUMO dynamics on PML by insolubilizing PML in THP-1 cells

Seishiro Hirano et al. Arch Toxicol. 2022 Feb.

Abstract

The functional roles of protein modification by small ubiquitin-like modifier (SUMO) proteins are not well understood compared to ubiquitination. Promyelocytic leukemia (PML) proteins are good substrates for SUMOylation, and PML-nuclear bodies (PML-NBs) may function as a platform for the PML SUMOylation. PML proteins are rapidly modified both with SUMO2/3 and SUMO1 after exposure to arsenite (As3+) and SUMOylated PML are further ubiquitinated and degraded by proteasomes. However, effects of As3+ on SUMO dynamics on PML-NBs are not well investigated. In the present study, we report that (1) the number and size of PML-NBs were regulated by SUMO E1-activating enzyme, (2) SUMO2/3 co-localized with PML irrespective of As3+ exposure and was restricted to PML-nuclear bodies (PML-NBs) via covalent binding in response to As3+, and (3) As3+-induced biochemical changes in PML were not modulated by ubiquitin-proteasome system (UPS) in THP-1 cells. Undifferentiated and differentiated THP-1 cells responded to As3+ similarly and PML proteins were changed from the detergent soluble to the insoluble form and further SUMOylated with SUMO2/3 and SUMO1. ML792, a SUMO E1 inhibitor, decreased the number of PML-NBs and reciprocally increased the size irrespective of exposure to As3+, which itself slightly decrease both the number and size of PML-NBs. TAK243, a ubiquitin E1 inhibitor, did not change the PML-NBs, while SUMOylated proteins accumulated in the TAK243-exposed cells. Proteasome inhibitors did not change the As3+-induced SUMOylation levels of PML. Co-localization and further restriction of SUMO2/3 to PML-NBs were confirmed by PML-transfected CHO-K1 cells. Collectively, SUMOylation regulates PML-NBs and As3+ restricts SUMO dynamics on PML by changing its solubility.

Keywords: Arsenic; Cytotoxicity; Promyelocytic leukemia-nuclear body (PML-NB); Small ubiquitin-like modifier (SUMO); Solubility; Ubiquitin.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Alkuraya F, Saadi I, Lund J, Turbe-Doan A, Morton C, Maas R (2006) SUMO1 haploinsufficiency leads to cleft lip and palate. Science 313(5794):1751. https://doi.org/10.1126/science.1128406 - DOI - PubMed
    1. Au W, Tam S, Fong B, Kwong Y (2008) Determinants of cerebrospinal fluid arsenic concentration in patients with acute promyelocytic leukemia on oral arsenic trioxide therapy. Blood 112(9):3587–3590. https://doi.org/10.1182/blood-2008-06-161000 - DOI - PubMed
    1. Baczyk D, Audette M, Drewlo S, Levytska K, Kingdom J (2017) SUMO-4: a novel functional candidate in the human placental protein SUMOylation machinery. PLoS One 12(5):e0178056. https://doi.org/10.1371/journal.pone.0178056 - DOI - PubMed - PMC
    1. Borden K, Lally J, Martin S, O’Reilly N, Solomon E, Freemont P (1996) In vivo and in vitro characterization of the B1 and B2 zinc-binding domains from the acute promyelocytic leukemia protooncoprotein PML. Proc Natl Acad Sci USA 93(4):1601–1606. https://doi.org/10.1073/pnas.93.4.1601 - DOI - PubMed - PMC
    1. Bosshart H, Heinzelmann M (2016) THP-1 cells as a model for human monocytes. Ann Transl Med 4(21):438. https://doi.org/10.21037/atm.2016.08.53 - DOI - PubMed - PMC

LinkOut - more resources